Abstract
Demethoxycurcumin (DMC) has anti-glioma effects in vitro and in subcutaneous xenotransplanted tumors. Our previous study confirmed that the molecule also has mild anti-glioma effects on orthotopic glioblastomas in vivo. In this study, we found that DMC-BH, a DMC analogue, exhibited more potent in vitro and in vivo activities than did DMC. DMC-BH was cytotoxic against various glioma cells including SHG-44, C6, U251, U87, A172 and primary glioma cells. DMC-BH activity was characterized by low acute toxicity and an appropriate pharmacokinetic profile. We evaluated the anti-tumor effects of DMC-BH in an ectopic xenograft model, an orthotopic glioblastoma xenograft model and a patient-derived tumor xenograft (PDTX) model. DMC-BH exhibited potent anti-tumor activity in both the ectopic xenograft and PDTX models. Indeed, bioluminescence measurements showed that DMC-BH exerted a significantly greater anti-tumor effect on orthotopic glioma growth than DMC. Immunohistochemical analysis revealed that DMC-BH inhibited expression of Ki67 and increased the incidence of TUNEL-positive cells. Western blotting showed that DMC-BH significantly decreased p-Akt and p-mTOR expression in orthotopic glioma tissues. These results suggest that the DMC ...Continue Reading
References
May 9, 2009·Biochemical and Biophysical Research Communications·Pratibha Mehta LuthraAmresh Prakash
Apr 10, 2010·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·H A RiinaJ A Boockvar
Mar 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Young Suk KimChang-Ok Suh
Mar 29, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Tzuu-Yuan HuangYi-Chiang Hsu
Jun 20, 2013·Journal of Agricultural and Food Chemistry·Jiunn-Min ShiehTzong-Der Way
Dec 18, 2013·Pharmacology & Therapeutics·Jiri Polivka, Filip Janku
Apr 18, 2014·The Journal of Pharmacology and Experimental Therapeutics·Esther P JaneIan F Pollack
Jul 6, 2014·Journal of Neuro-oncology·Ye SongSongtao Qi
Oct 30, 2014·Molecular Medicine Reports·Xiaoyang LiuLing Jing
Jan 17, 2015·Journal of Agricultural and Food Chemistry·Yu-Ning TengHui-Yi Lin
Oct 16, 2015·Neuromolecular Medicine·Lei Shi, Guan Sun
Jul 23, 2016·The Journal of Molecular Diagnostics : JMD·Fausto J RodriguezMing-Tseh Lin
Oct 21, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liang LengLei Shi
Jun 8, 2017·Oncotarget·Long ChenYouxin Zhou
Jul 9, 2017·Colloids and Surfaces. B, Biointerfaces·Bomi KimYu Seok Youn
Jul 16, 2017·Colloids and Surfaces. B, Biointerfaces·He-Lin XuYing-Zheng Zhao
Jul 20, 2017·Drug Design, Development and Therapy·Kai-Hong ZhaoWen-Bin Li
Aug 7, 2017·Biochemical and Biophysical Research Communications·Lakshya MittalRaji Sundararajan
Aug 28, 2017·Gene·Te LiuYibing Si
Sep 19, 2017·ANZ Journal of Surgery·Dasantha JayamanneMichael F Back
Sep 26, 2017·Oncology Letters·Lei ZhangChun Luo
Oct 8, 2017·World Journal of Surgical Oncology·Qian SunHao Jiang
Mar 27, 2018·Journal of Cellular Biochemistry·Lei Shi, Guan Sun
May 2, 2018·Scientific Reports·Arshad A PandithNiyaz A Naikoo
Apr 6, 2019·Neurotoxicity Research·Faezeh GhasemiAmirhossein Sahebkar